Related references
Note: Only part of the references are listed.Synthesis and pharmacological evaluation of a novel AT1 angiotensin II receptor antagonist with anti-hypertension and anti-tumor effects
Xiaolu Bao et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2015)
Design, synthesis and biological evaluation of new 5-nitro benzimidazole derivatives as AT1 antagonists with anti-hypertension activities
Weibo Zhu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Ability of the new AT1 receptor blocker azilsartan to block angiotensin II-induced AT1 receptor activation after wash-out
Shin-ichiro Miura et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2014)
Effect of azilsartan versus candesartan on nocturnal blood pressure variation in Japanese patients with essential hypertension
Hiromi Rakugi et al.
BLOOD PRESSURE (2013)
Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan
Shin-ichiro Miura et al.
HYPERTENSION RESEARCH (2013)
Synthesis and biological evaluation of new fluorine substituted derivatives as angiotensin II receptor antagonists with anti-hypertension and anti-tumor effects
Ya-jing Da et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Comparison of the efficacy and safety of azilsartan with that of candesartan cilexetil in Japanese patients with grade I-II essential hypertension: a randomized, double-blind clinical study
Hiromi Rakugi et al.
HYPERTENSION RESEARCH (2012)
Comparison of the Novel Angiotensin II Receptor Blocker Azilsartan Medoxomil vs Valsartan by Ambulatory Blood Pressure Monitoring
Domenic Sica et al.
JOURNAL OF CLINICAL HYPERTENSION (2011)
Discovery of Ν-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonists
N Murugesan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Drugs targeting the renin-angiotensin-aldosterone system
MA Zaman et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Share Paper
